Trials / Not Yet Recruiting
Not Yet RecruitingNCT06999213
Lower Limb ExoNET: Development and Evaluation for Gait Assistance With Stroke Survivors
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Shirley Ryan AbilityLab · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Stroke-related gait impairments, such as poor limb coordination, imbalance, and reduced push-off strength, are often addressed using robotic systems or electrical stimulation, which can be costly, invasive, or insufficient for long-term recovery. Current devices often assist movement but fail to promote functional motor learning. Research supports rehabilitation strategies that amplify gait errors to drive neuroplasticity and adaptation. The LegExoNET (Exoskeletal Network for Elastic Torque) is a novel, passive wearable exoskeleton designed to address this need by enabling both assistive and therapeutic gait training. It stores and releases elastic energy to aid movement while allowing natural joint motion. The system aims to support individuals post-stroke transitioning to independent rehabilitation by offering a lightweight, affordable, and adaptive solution. Initial testing will focus on healthy individuals to assess safety and feasibility before expanding to stroke populations. The LegExoNET has the potential to enhance gait recovery and reduce therapist burden through error augmentation and personalized support, both in clinical and at-home settings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Assist | The device will provide assistive torques to support either ankle, knee, and/or hip movements. |
| OTHER | Resist | The device will apply resistive torques to exaggerate gait asymmetries, facilitating error augmentation. |
| OTHER | Slack | The device will be worn but will not generate any torque. |
Timeline
- Start date
- 2026-01-31
- Primary completion
- 2029-12-31
- Completion
- 2029-12-31
- First posted
- 2025-05-31
- Last updated
- 2025-07-30
Source: ClinicalTrials.gov record NCT06999213. Inclusion in this directory is not an endorsement.